Blog

Global Breast Cancer Initiative Implementation Planning Workshop by WHO – City Cancer Challenge

City Cancer Challenge/LinkedIn

Nov 30, 2024, 23:26

Global Breast Cancer Initiative Implementation Planning Workshop by WHO – City Cancer Challenge

City Cancer Challenge shared a post on LinkedIn:

“Cali is at the forefront of a global movement as local and international leaders gather for the Global Breast Cancer Initiative (GBCI) Implementation Planning Workshop. Developed by the World Health Organization (WHO), the GBCI framework is being implemented at the city level by C/Can, empowering cities like Cali to transform breast cancer care.

Since joining C/Can in 2017, Cali has become a hub of innovation in cancer care. Now, the city is developing a Breast Cancer Action Plan (BCAP) tailored to its unique needs, aiming to improve early detection, diagnosis, and treatment. With breast cancer as the most diagnosed cancer among women worldwide, this initiative holds the power to save lives and inspire similar efforts across Latin America.

Learn how Cali is leading the fight against breast cancer and shaping a healthier future for women across the region.

A special thank you to all the experts and advocates driving this crucial work forward in Colombia and around the world! Your dedication is inspiring change. We’d like to extend our thank you to IFPMA for its convening role and to Amgen, AstraZeneca, Bristol Myers Squibb, and MSD who provided essential funding through which C/Can can operate the GBCI partnership.”

Breast Cancer

More posts featuring City Cancer Challenge.

America Amgen AstraZeneca BCAP Breast Cancer Breast Cancer care Bristol Myers Squibb Cali cancer cancer care City Cancer Challenge Colombia diagnosis GBCI GBCI partnership IFPMA international leaders MSD OncoDaily Oncology treatment WHO

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC